Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Narrative (Details)

v3.22.2.2
Revenue Recognition - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
unit
Sep. 30, 2021
USD ($)
unit
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jul. 16, 2021
shares
Deferred Revenue Arrangement [Line Items]                      
Current portion of contract assets $ 5,291           $ 5,291   $ 1,459    
Contract assets, noncurrent 1,524           1,524   3,418    
Revenue recognized from prior year deferred revenue balance 1,300   $ 500       5,995 $ 2,300      
Deferred asset related to commissions 7,000           7,000   5,400    
Amortized commissions 1,200   1,400       2,400 2,000      
General and administrative $ 8,839 $ 10,817 $ 7,535 $ 1,471 $ 3,052 $ 4,523 $ 29,268 $ 12,058 $ 19,869 $ 5,530  
Give Evolv LLC                      
Deferred Revenue Arrangement [Line Items]                      
Initial contribution of common shares (in shares) | shares                     517,500
Number of Evolv Express units donated | unit             6 0      
General and administrative             $ 200